Atossa Therapeutics Inc (NASDAQ:ATOS)
| 0.7713 BATS BZX Real-Time Price As of 2:18pm ET |  +0.0009 / +0.12%Today’s Change | 0.50 Today|||52-Week Range 1.39 | +45.94% Year-to-Date |
Latest ATOS News | Press Releases
No recent news for Atossa Therapeutics Inc.
Today’s Trading
| Previous close | 0.77 |
| Today’s open | 0.78 |
| Day’s range | 0.75 - 0.82 |
| Volume | 16,456 |
| Average volume (3 months) | 822,985 |
| Market cap | $95.6M |
Data as of 2:18pm ET, 09/26/2023
Growth & Valuation
| Earnings growth (last year) | -20.83% |
| Earnings growth (this year) | -14.29% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 0.82 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| CDXCChromadex Corp | -0.06 | -4.32% |
| CDTXCidara Therapeutics ... | +0.02 | +1.93% |
| CATXPerspective Therapeu... | +0.00 | +0.87% |
| LFVNLifeVantage Corp | +0.12 | +1.82% |
Data as of 2:15pm ET, 09/26/2023
Financials
| Next reporting date | November 15, 2023 |
| EPS forecast (this quarter) | -$0.07 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$27.0M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Seattle, Washington |
Forecasts
